| Bupropion | |
|---|---|
| Salts [] | |
|---|---|
| %!s( | |
| %!s( | |
| %!s( | |
| Molecular structure via molpic based on CDK |
| Physical properties [] | |
|---|---|
| Molecular mass | 239.74 g/mol [1] |
| Appearance | Pale yellow oil [1] |
| Melting point | 233-234 °C [1] |
| Boiling point | 52 °C [1] |
| Solubility | Very hygroscopic and susceptible to decomposition [1] |
| Predicted LogP | 3.2 [1] |
| Structural Identifiers [] | |
|---|---|
| Molecular formula | C13H18ClNO [1] |
| IUPAC name | 2-(tert-butylamino)-1-(3-chlorophenyl)propan-1-one [1] |
| SMILES | CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C [1] |
| InChI | InChI=1S/C13H18ClNO/c1-9(15-13(2,3)4)12(16)10-6-5-7-11(14)8-10/h5-9,15H,1-4H3 [1] |
| InChIKey | SNPPWIUOZRMYNY-UHFFFAOYSA-N [1] |
Bupropion
Bupropion (also known as Amfebutamone, Amfebutamon, amfebutamonum, Amfebutamona, Elontril, Bupropion slow release, bupropione, Bupropion extended release, α-(tert-butylamino)-m-chloropropiophenone or 1-(3-chlorophenyl)-2-((1,1-dimethylethyl)amino)-1-propanone) is a stimulant substance of the cathinone class.
Chemistry
Salts []
Stereochemistry []
Bupropion is a racemic mixture of the enantiomers
| Stereoisomers |
|---|
Pharmacology
Bupropion acts as a prodrug for:
| Active metabolites [] |
|---|
Subjective effects
| Anodyne Usernotes [] | |
|---|---|
| 0xea / Bupropion[hydrochloride] via Oral and Intravenous at 150mg oral and 300mg intravenous |
|
See also []
External links []
References []
National Center for Biotechnology Information. PubChem Compound Summary for CID 444, Bupropion. Accessed July 19, 2025. https://pubchem.ncbi.nlm.nih.gov/compound/444
U.S. Food and Drug Administration; National Center for Advancing Translational Sciences. Bupropion. UNII: 01ZG3TPX31. Global Substance Registration System. Accessed July 19, 2025. https://gsrs.ncats.nih.gov/ginas/app/beta/substances/01ZG3TPX31
Anodyne